EdRIP unveils new €345 million fund

Edmond de Rothschild Investment Partners closed its fifth fund, BioDiscovery 5, at €345 million ($428 million), one of the largest European VC funds focused on life sciences ever, according to BioCentury’s BCIQ database. The fund topped an initial target of €250 million ($310.1 million) and was just shy of the revised hard cap of €350 million ($434.2 million).

The firm’s previous fund, BioDiscovery 4, closed at €192 million ($265.2 million) in 2013...